Curaleaf Holdings Statistics

Total Valuation

TSX:CURA has a market cap or net worth of CAD 1.01 billion. The enterprise value is 2.58 billion.

Market Cap	1.01B
Enterprise Value	2.58B

Important Dates

The next estimated earnings date is Wednesday, May 7, 2025.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:CURA has 756.37 million shares outstanding. The number of shares has increased by 2.31% in one year.

Current Share Class	n/a
Shares Outstanding	756.37M
Shares Change (YoY)	+2.31%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	19.60%
Owned by Institutions (%)	10.28%
Float	602.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.52
PB Ratio	0.71
P/TBV Ratio	n/a
P/FCF Ratio	10.15
P/OCF Ratio	4.33
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.82, with an EV/FCF ratio of 25.82.

EV / Earnings	-7.52
EV / Sales	1.33
EV / EBITDA	5.82
EV / EBIT	88.73
EV / FCF	25.82

Financial Position

The company has a current ratio of 1.11, with a Debt / Equity ratio of 1.07.

Current Ratio	1.11
Quick Ratio	0.45
Debt / Equity	1.07
Debt / EBITDA	3.45
Debt / FCF	15.31
Interest Coverage	0.20

Financial Efficiency

Return on equity (ROE) is -19.98% and return on invested capital (ROIC) is 0.58%.

Return on Equity (ROE)	-19.98%
Return on Assets (ROA)	0.42%
Return on Invested Capital (ROIC)	0.58%
Return on Capital Employed (ROCE)	0.79%
Revenue Per Employee	350,077
Profits Per Employee	-62,092
Employee Count	5,519
Asset Turnover	0.44
Inventory Turnover	3.22

Taxes

In the past 12 months, TSX:CURA has paid 157.52 million in taxes.

Income Tax	157.52M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.55% in the last 52 weeks. The beta is 1.27, so TSX:CURA's price volatility has been higher than the market average.

Beta (5Y)	1.27
52-Week Price Change	-80.55%
50-Day Moving Average	1.55
200-Day Moving Average	3.11
Relative Strength Index (RSI)	53.52
Average Volume (20 Days)	413,471

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:CURA had revenue of CAD 1.93 billion and -342.69 million in losses. Loss per share was -0.46.

Revenue	1.93B
Gross Profit	919.78M
Operating Income	29.06M
Pretax Income	-169.25M
Net Income	-342.69M
EBITDA	364.65M
EBIT	29.06M
Loss Per Share	-0.46

Full Income Statement

Balance Sheet

The company has 154.28 million in cash and 1.53 billion in debt, giving a net cash position of -1.37 billion or -1.82 per share.

Cash & Cash Equivalents	154.28M
Total Debt	1.53B
Net Cash	-1.37B
Net Cash Per Share	-1.82
Equity (Book Value)	1.43B
Book Value Per Share	1.65
Working Capital	60.08M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 233.91 million and capital expenditures -134.03 million, giving a free cash flow of 99.88 million.

Operating Cash Flow	233.91M
Capital Expenditures	-134.03M
Free Cash Flow	99.88M
FCF Per Share	0.13

Full Cash Flow Statement

Margins

Gross margin is 47.61%, with operating and profit margins of 1.50% and -16.04%.

Gross Margin	47.61%
Operating Margin	1.50%
Pretax Margin	-8.76%
Profit Margin	-16.04%
EBITDA Margin	18.87%
EBIT Margin	1.50%
FCF Margin	5.17%

Dividends & Yields

TSX:CURA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.31%
Shareholder Yield	-2.31%
Earnings Yield	-33.81%
FCF Yield	9.85%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSX:CURA has an Altman Z-Score of 0.73 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.73
Piotroski F-Score	1